Track topics on Twitter Track topics that are important to you
In this issue, we are fortunate to bring readers a Guest Editorial from Michael C. Schweitz, MD, a member of the board of directors for the Coalition for State Rheumatology Organizations and a member of the Healio Rheumatology Peer Perspective Board, and Ally Lopshire, JD, a government affairs specialist at WJ Weiser & Associates. They share their opinions on the role of pharmacy benefit managers acting as the intermediaries between insurers, manufacturers and pharmacies. This is an important and timely topic, and I encourage readers to get involved in the mission of the Alliance for Transparent and Affordable Prescriptions.— Leonard H. Calabrese, DO
Original Article: Pharmacy Benefit Managers: Drug Industry’s Hidden MiddlemenNEXT ARTICLE
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...
Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.